Aptorum Group Limited (NASDAQ:APM) Sees Significant Decrease in Short Interest

Aptorum Group Limited (NASDAQ:APM) saw a large decline in short interest in January. As of January 15th, there was short interest totalling 78,800 shares, a decline of 57.4% from the December 31st total of 184,800 shares. Based on an average daily volume of 2,220,000 shares, the short-interest ratio is presently 0.0 days. Approximately 2.0% of the shares of the stock are short sold.

Aptorum Group Trading Down 5.7 %

Shares of APM stock traded down $0.07 on Friday, reaching $1.16. The company’s stock had a trading volume of 136,175 shares, compared to its average volume of 1,004,816. The stock’s fifty day simple moving average is $1.12 and its 200-day simple moving average is $1.90. Aptorum Group has a 1 year low of $0.46 and a 1 year high of $17.49.

Aptorum Group Company Profile

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.